Cite
HARVARD Citation
Garland, S. et al. (2022). Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants. Human vaccines & immunotherapeutics. 18 (6), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Garland, S. et al. (2022). Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants. Human vaccines & immunotherapeutics. 18 (6), p. . [Online].